IPO Boutique

Relypsa IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Relypsa, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
RelypsaRLYP - $16.00-$19.00 $11.00 $12.596.9 million11/15/2013
Morgan Stanley, BofA Merrill Lynch
Co-Manager(s):
Stifel, Cowen & Co., Wedbush PacGrow Life Sciences
Health Care
Filing(s):

Filed 2013-09-27



Relypsa Quote & Chart - Click for current quote - RLYP

About Relypsa (adapted from Relypsa prospectus):
They are a pharmaceutical company focused on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "RLYP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved